Health Headlines 3/6/06
New Anti-drug Program Shows 'phenomenal' Success By Focusing On Positives ~ Click here.
UCI Researchers Identify First Compound To Block Progression Of Alzheimer's Disease ~ Click here.
Anti-inflammatory Drug's Potentially Deadly Side Effect Found To Be Rare ~ Click here.
FDA Approves Rituxan® - The First Targeted B-Cell Therapy For Treatment Of Moderate-To-Severe Rheumatoid Arthritis ~ Click here.
Moderate To Severe Psoriasis - Remicade® (infliximab) Phase 3 Data Show Rapid/Significant Improvement And Long-Term Response ~ Click here.
Screening May Over-diagnose 1 In 10 Breast Cancers ~ Click here.
UCI Researchers Identify First Compound To Block Progression Of Alzheimer's Disease ~ Click here.
Anti-inflammatory Drug's Potentially Deadly Side Effect Found To Be Rare ~ Click here.
FDA Approves Rituxan® - The First Targeted B-Cell Therapy For Treatment Of Moderate-To-Severe Rheumatoid Arthritis ~ Click here.
Moderate To Severe Psoriasis - Remicade® (infliximab) Phase 3 Data Show Rapid/Significant Improvement And Long-Term Response ~ Click here.
Screening May Over-diagnose 1 In 10 Breast Cancers ~ Click here.
posted by Kim @ 3:05 PM
0 Comments:
Post a Comment
<< Home